Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,169 | -14,369 | -25,295 | -9,307 | -14,385 |
| Depreciation Amortization | 3 | -288 | 7 | -32 | -29 |
| Accounts payable and accrued liabilities | -168 | N/A | N/A | N/A | N/A |
| Other Working Capital | 357 | 149 | 655 | -178 | -302 |
| Other Operating Activity | 2,384 | -4,332 | 9,212 | -3,710 | -2,636 |
| Operating Cash Flow | $-3,593 | $-18,839 | $-15,420 | $-13,227 | $-17,352 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 11,950 | -9,298 | 4,493 | 9,617 |
| PPE Investments | -25 | -39 | -75 | -9 | -62 |
| Investing Cash Flow | $-25 | $11,911 | $-9,373 | $4,484 | $9,554 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,706 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 6,873 | 22,114 | 10,122 | 8,171 |
| Other Financing Activity | -2 | -100 | 0 | 0 | 0 |
| Financing Cash Flow | $4,704 | $6,773 | $22,114 | $10,122 | $8,171 |
| Beginning Cash Position | 451 | 8,899 | 11,579 | 10,199 | 9,826 |
| End Cash Position | 1,537 | 8,744 | 8,899 | 11,579 | 10,199 |
| Net Cash Flow | $1,086 | $-155 | $-2,679 | $1,379 | $373 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,593 | -18,839 | -15,420 | -13,227 | -17,352 |
| Capital Expenditure | -25 | -39 | -75 | -9 | -62 |
| Free Cash Flow | -3,618 | -18,878 | -15,495 | -13,236 | -17,414 |